Cite
Occurrence of thyroid autoimmunity, metabolic disorders and malignancy in patients with primary, non-syndromic hyperparathyroidism
MLA
Efstratios Kardalas, et al. “Occurrence of Thyroid Autoimmunity, Metabolic Disorders and Malignancy in Patients with Primary, Non-Syndromic Hyperparathyroidism.” Endocrine Abstracts, May 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........93ec0c209d39b9cdde879df3d149abfe&authtype=sso&custid=ns315887.
APA
Efstratios Kardalas, Georgia Ntali, Vassiliadi Dimitra Argyro, & Stylianos Tsagarakis. (2023). Occurrence of thyroid autoimmunity, metabolic disorders and malignancy in patients with primary, non-syndromic hyperparathyroidism. Endocrine Abstracts.
Chicago
Efstratios Kardalas, Georgia Ntali, Vassiliadi Dimitra Argyro, and Stylianos Tsagarakis. 2023. “Occurrence of Thyroid Autoimmunity, Metabolic Disorders and Malignancy in Patients with Primary, Non-Syndromic Hyperparathyroidism.” Endocrine Abstracts, May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........93ec0c209d39b9cdde879df3d149abfe&authtype=sso&custid=ns315887.